![Jennifer A. MacDiarmid](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profiel
Jennifer A.
MacDiarmid is the founder.
She founded EnGeneIC Pty Ltd.
in 2001 and currently holds the title of Co-Chief Executive Officer & Director.
In addition to her founding position, Dr. MacDiarmid has also worked as a Research Scientist at CSIRO's ICT Sector Advisory Council.
Actieve functies van Jennifer A. MacDiarmid
Bedrijven | Functie | Begin |
---|---|---|
EnGeneIC Pty Ltd.
![]() EnGeneIC Pty Ltd. BiotechnologyHealth Technology EnGeneIC Pty Ltd. develops and commercializes novel concepts for the targeted delivery of drugs and other therapeutic molecules used in the treatment of cancer. It offers targeted drug delivery, gene silencing, canine cancers and principal characteristics technology solutions. The company was founded by Jennifer A. MacDiarmid and Himanshu Brahmbhatt in 2001 and is headquartered in Sydney, Australia. | Oprichter | 29-10-2010 |
Eerdere bekende functies van Jennifer A. MacDiarmid
Bedrijven | Functie | Einde |
---|---|---|
CSIRO's ICT Sector Advisory Council | Hoofd Techniek/Wetenschap/O&O | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
EnGeneIC Pty Ltd.
![]() EnGeneIC Pty Ltd. BiotechnologyHealth Technology EnGeneIC Pty Ltd. develops and commercializes novel concepts for the targeted delivery of drugs and other therapeutic molecules used in the treatment of cancer. It offers targeted drug delivery, gene silencing, canine cancers and principal characteristics technology solutions. The company was founded by Jennifer A. MacDiarmid and Himanshu Brahmbhatt in 2001 and is headquartered in Sydney, Australia. | Health Technology |
CSIRO's ICT Sector Advisory Council |